Suchergebnisse - "Pearson, Steven D"

PubPharm (253)

91

The ICER Value Framework : Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2018

von Pearson, S.

92

Gene therapy : evidence, value and affordability in the US health care system

enthalten in: Journal of comparative effectiveness research | 2018

von Hampson, G. | Towse, A. | Pearson, S. | +2

93

Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States

enthalten in: Journal of managed care & specialty pharmacy | 2018

von Carlson, J. | Guzauskas, G. | Chapman, R. | +6

CommentIn: J Manag Care Spec Pharm. 2018 Jul;24(7):712-713. - PMID 29952702

94

Indication-specific pricing of pharmaceuticals in the US healthcare system

enthalten in: Journal of comparative effectiveness research | 2017

von Pearson, S. | Dreitlein, W. | Henshall, C. | +1

95

Conflicts of Interest Reported in an Abbreviated Time Frame-Reply

enthalten in: JAMA internal medicine | 2017

von Jefferson, A. | Pearson, S.

CommentOn: JAMA Intern Med. 2017 Mar 1;177(3):352-357. - PMID 28114439

96

Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction

enthalten in: Annals of internal medicine | 2017

von Sandhu, A. | Ollendorf, D. | Chapman, R. | +2

CommentOn: Ann Intern Med. 2016 Nov 15;165(10 ):681-689. - PMID 27571284

97

Conflict of Interest in Seminal Hepatitis C Virus and Cholesterol Management Guidelines

enthalten in: JAMA internal medicine | 2017

von Jefferson, A. | Pearson, S.

CommentIn: JAMA Intern Med. 2017 Jul 1;177(7):1059-1060. - PMID 28672362

98

Assessing the value of mepolizumab for severe eosinophilic asthma : a cost-effectiveness analysis

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2017

von Whittington, M. | McQueen, R. | Ollendorf, D. | +4

99

Developing a Value Framework : The Need to Reflect the Opportunity Costs of Funding Decisions

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2017

von Sculpher, M. | Claxton, K. | Pearson, S.

100

Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis

enthalten in: Annals of allergy, asthma, & immunology | 2017

von Whittington, M. | McQueen, R. | Ollendorf, D. | +4